Comparative Pharmacology
Head-to-head clinical analysis: AK FLUOR 10 versus EVANS BLUE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AK FLUOR 10 versus EVANS BLUE.
AK-FLUOR 10% vs EVANS BLUE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluorescein sodium is a diagnostic dye that absorbs light in the blue spectrum (465-490 nm) and emits green-yellow fluorescence (520-530 nm). It is used to visualize blood flow, detect corneal abrasions, and assess vascular integrity by highlighting areas of leakage or damage.
Evans Blue is a diazo dye that binds reversibly to plasma proteins, primarily albumin. Its primary utility is as a visual indicator for the estimation of blood volume or plasma volume via dye dilution technique. It also has histological applications for staining myelin sheaths and detecting blood-brain barrier disruption.
Intravenous injection: 5-10 mL (500-1000 mg fluorescein sodium) given rapidly over 4-5 seconds.
Adults: 0.5-1.0 mL of 0.5% solution (2.5-5 mg) IV bolus for determination of blood volume. Repeat doses must be separated by at least 1 hour due to slow clearance.
None Documented
None Documented
Terminal elimination half-life is approximately 1-2 minutes in patients with normal renal function. This short half-life reflects rapid redistribution and renal clearance.
Terminal elimination half-life ranges from 2 to 12 hours, mean approximately 6 hours; prolonged in hepatic impairment or decreased albumin levels.
Primarily renal (unchanged). Approximately 80-90% of an administered dose is excreted unchanged in urine within 24 hours. Biliary/fecal excretion is minimal (<5%).
Primarily excreted unchanged in bile (80-90%) into feces; renal elimination accounts for <5% due to high protein binding.
Category C
Category C
Diagnostic Dye
Diagnostic Dye